(Q44474633)

English

Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

S Tomari

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

H Matsuse

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

I Machida

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Y Kondo

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

T Kawano

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Y Obase

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

C Fukushima

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

T Shimoda

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

S Kohno

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

795-801

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Activation and localization of transcription factor, nuclear factor-kappaB, in asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

The role of nuclear factor-kappa B in pulmonary diseases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Long-acting inhaled beta(2)-agonist therapy in asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Development of a sensitive multi-well colorimetric assay for active NFkappaB

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

The contribution of NF-kappa B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Phospholipase A2 inhibitors and leukotriene synthesis inhibitors block TNF-induced NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Functional coupling between secretory and cytosolic phospholipase A2 modulates tumor necrosis factor-alpha- and interleukin-1beta-induced NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Priming of alveolar macrophages by leukotriene D(4): potentiation of inflammation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Cytokines as mediators of chronic asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01656.X

21 January 2018

Identifiers

10.1046/J.1365-2222.2003.01656.X

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44474633&oldid=2025217827"